Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data

Detalles Bibliográficos
Autor principal: Meryer, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437187/
https://www.ncbi.nlm.nih.gov/pubmed/14613346
http://dx.doi.org/10.18553/jmcp.2003.9.2.168
_version_ 1785092458695098368
author Meryer, Christina
author_facet Meryer, Christina
author_sort Meryer, Christina
collection PubMed
description
format Online
Article
Text
id pubmed-10437187
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104371872023-08-21 Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data Meryer, Christina J Manag Care Pharm Formulary Management Academy of Managed Care Pharmacy 2003-03 /pmc/articles/PMC10437187/ /pubmed/14613346 http://dx.doi.org/10.18553/jmcp.2003.9.2.168 Text en Copyright © 2003, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Formulary Management
Meryer, Christina
Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data
title Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data
title_full Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data
title_fullStr Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data
title_full_unstemmed Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data
title_short Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data
title_sort pharmacy benefit forecast for a new interferon beta-1a for the treatment of multiple sclerosis: development of a first-line decision tool for pharmacy-budget planning using administrative claims data
topic Formulary Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437187/
https://www.ncbi.nlm.nih.gov/pubmed/14613346
http://dx.doi.org/10.18553/jmcp.2003.9.2.168
work_keys_str_mv AT meryerchristina pharmacybenefitforecastforanewinterferonbeta1aforthetreatmentofmultiplesclerosisdevelopmentofafirstlinedecisiontoolforpharmacybudgetplanningusingadministrativeclaimsdata

Ejemplares similares